Compare BRN & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BRN | SINT |
|---|---|---|
| Founded | 1956 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.7M | 11.7M |
| IPO Year | 1995 | 2007 |
| Metric | BRN | SINT |
|---|---|---|
| Price | $0.87 | $1.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $9.25 |
| AVG Volume (30 Days) | ★ 28.7K | 26.1K |
| Earning Date | 12-18-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 59.45 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $13,697,000.00 | $1,018,000.00 |
| Revenue This Year | N/A | $217.16 |
| Revenue Next Year | N/A | $86.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.82 | $1.18 |
| 52 Week High | $1.40 | $4.46 |
| Indicator | BRN | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 45.09 | 23.51 |
| Support Level | $0.84 | N/A |
| Resistance Level | $0.92 | $1.86 |
| Average True Range (ATR) | 0.03 | 0.15 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 48.94 | 2.97 |
Barnwell Industries Inc is an oil and gas company engaged in the acquisition, development, production, and sale of crude oil and natural gas. The Company operates through two segments: the Oil and Natural Gas segment, which focuses on oil and natural gas development, production, acquisitions, and sales in the United States and Canada; and the Land Investment segment, which owns leasehold land interests in Hawaii. The Company generates the majority of its revenue from the Oil and Natural Gas segment. The company operates in two geographic regions, the United States and Canada, with Canada contributing the majority of revenue.
SINTX Technologies Inc is a biomaterials company that develops, manufactures, and commercializes patented and proprietary silicon nitride ceramic biomaterials, composites, devices, and related ceramics technologies for other medical and specialized industrial applications. SINTX has 20 years' experience innovating silicon nitride technologies and operates under a quality management system certified to ISO 13485:2016 and AS9100D, with a product portfolio that includes insulators for Tier 1 aerospace suppliers, the FDA-cleared SiNAPTIC Foot & Ankle Osteotomy Wedge System for reconstructive surgery, OEM manufacturing of FDA-cleared spinal implants, and its SiNERGY technology platform being developed for biocomposite and 3D printing applications.